前房注射甲强龙在晶状体超声乳化人工晶状体植入联合房角分离术中的应用

The application of anterior chamber injection of methylprednisolone in phacoemulsification combined with intraocular lens implantation and goniosynechialysis

目的探讨前房注射甲强龙在控制急性闭角型青光眼晶状体超声乳化房角分离术后前房炎症反应的效果。方法对合并白内障的原发性急性闭角型青光眼行超声乳化人工晶状体植入联合房角分离术。实验组（23例，24眼）。术毕即刻给予0．5mg甲强龙前房内注射，对照组（24例，25眼）不注射。比较术后1d、3d、1周、2周前房炎症反应及视力、眼压、角膜、瞳孔。结果术后不同时间比较：对照组房水闪光较实验组程度重且吸收慢。结论前房内注射甲强龙能有效控制急性闭角型青光眼晶状体超声乳化房角分离术后前房炎症反应。

Objective To evaluate the safety and effectiveness of anterior chamber injection of methylprednisolone in the control of anterior chamber inflammation in acute angle-closure glaucoma after phacoemulsification with goniosynechialysis. Methods 0.5 mg of methylprednisolone was given in anterior chamber of experimental group immediately after phacoemulsification and intraoeular lens implantation combined with goniosynechialysis, the control group was not given. The observing items included the anterior chamber inflammation, visual acuity, intraoeular pressure and pupil at one day, three days, a week and two weeks after surgery. Results The inflammation of anterior chamber in control group was more severe and was absorbed more slowly compared with the experimental group in different times after surgery. The visual acuity of 41 eyes （83.67%） was improved two weeks after surgery. Conclusion The anterior chamber injection of methylprednisolone is safe and effective to control the anterior chamber inflammation for acute angleclosure glaucoma after phaco-emulsilication and goniosynechialysis.